HM (n = 78) | HM-like (n = 41) | Non-HM (n = 401) | P value | ||
---|---|---|---|---|---|
Stage | I | 14 (17.9%) | 10 (24.4%) | 62 (15.5%) | NS |
II | 45 (57.7%) | 16 (39.0%) | 123 (30.9%) | *** | |
III | 14 (17.9%) | 13 (31.7%) | 125 (31.2%) | * | |
IV | 3 (3.8%) | 1 (2.4%) | 72 (18.0%) | *** | |
No data | 2 (2.6%) | 1 (2.4%) | 19 (4.7%) | *** | |
Location | Ascending | 50 (64.1%) | 21 (51.2%) | 115 (28.7%) | *** |
Transverse | 10 (12.8%) | 8 (19.5%) | 16 (4.0%) | *** | |
Descending | 12 (15.4%) | 11 (26.8%) | 253 (63.1%) | *** | |
No data | 6 (7.7%) | 1 (2.4%) | 17 (4.2%) | ||
Mutational Burden | Median of mutations/Megabase | 44.9 | 3.9 | 3.5 | |
MSI-status | MSI-H | 61 (78.2%) | 6 (14.6%) | 3 (0.7%) | *** |
MSS/MSI-L | 11 (14.1%) | 34 (82.9%) | 377 (94.0%) | *** | |
Indeterminate | 6 (7.7%) | 1 (2.4%) | 21 (5.2%) | – | |
Pol-ε exonuclease domain mutation | 15 (19.2%) | 0 | 0 |